Sangui Biotech International (Sangui Biotech International) Total Assets : $0.09 Mil (As of Mar. 2023)

View and export this data going back to . Start your Free Trial

What is Sangui Biotech International Total Assets?

Sangui Biotech International's Total Assets for the quarter that ended in Mar. 2023 was $0.09 Mil.

Total Assets is connected with ROA %. Sangui Biotech International's annualized ROA % for the quarter that ended in Mar. 2023 was -161.70%. Total Assets is also linked to Revenue through Asset Turnover. Sangui Biotech International's Asset Turnover for the quarter that ended in Mar. 2023 was 0.20.

Sangui Biotech International Total Assets Historical Data

The historical data trend for Sangui Biotech International's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sangui Biotech International Total Assets Chart

Sangui Biotech International Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Total Assets

Get a 7-Day Free Trial

0.10

0.08

0.13

Sangui Biotech International Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Total Assets	Get a 7-Day Free Trial															0.19	0.13	0.13	0.10	0.09

Sangui Biotech International Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Sangui Biotech International's Total Assets for the fiscal year that ended in Jun. 2022 is calculated as

Total Assets	=	Total Equity (A: Jun. 2022 )	+	Total Liabilities (A: Jun. 2022 )
	=	-0.895	+	1.026
	=	0.13

Sangui Biotech International's Total Assets for the quarter that ended in Mar. 2023 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2023 )	+	Total Liabilities (Q: Mar. 2023 )
	=	-1.01	+	1.099
	=	0.09

Sangui Biotech International (OTCPK:SGBI) Total Assets Explanation

Total Assets is connected with ROA %.

Sangui Biotech International's annualized ROA % for the quarter that ended in Mar. 2023 is

ROA %	=	Net Income (Q: Mar. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Mar. 2023 ))	/ count )
	=	-0.152	/	( (0.099	+	0.089)	/ 2 )
	=	-0.152	/	0.094
	=	-161.70 %

Note: The Net Income data used here is four times the quarterly (Mar. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Sangui Biotech International's Asset Turnover for the quarter that ended in Mar. 2023 is

	Asset Turnover
=	Revenue (Q: Mar. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Mar. 2023 ))	/ count )
=	0.019	/	( (0.099	+	0.089)	/ 2 )
=	0.019	/	0.094
=	0.20

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Sangui Biotech International Total Assets Related Terms

Thank you for viewing the detailed overview of Sangui Biotech International's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Sangui Biotech International (Sangui Biotech International) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sangui Biotech International Inc (OTCPK:SGBI) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

SBH:Germany

Address

Bleichenbrucke 9, Hamburg, DEU, 20354

Website

http://www.sanguibiotech.com

Sangui Biotech International Inc develops pharmaceutical, medical and cosmetic products, through its subsidiary. The company develops oxygen carriers for providing oxygen transport in humans due to acute or chronic lack of oxygen and in the case of chronic wounds. It has also developed external applications of oxygen transporters in the form of sprays for healing chronic wounds and gels and emulsions for the regeneration of the skin. The products offered are artificial oxygen carriers; Chitoskin wound pads; and haemoglobin-based wound spray technology sold under the brand name Granulox. It derives revenue from licensing fees on sales of its wound spray product.

Executives

Hubertus Schmelz	director	NEUER WALL 54, HAMBURG 2M D-20354
Joachim Fleing	director	ALFRED HERRHAUSENSTR 44, WITTEN 2M 58455
Thomas Striepe	director	NEUER WALL 54, HAMBURG 2M D-20354
Wolfgang Barnikol	director	ALFRED HERRHAUSEN STR 44, WITTEN 2M 58455
Lutz Joachim	director	ALFRED-HERRHAUSEN-ST. 44, WITTEN 2M 58455
Christoph Ludz	director	SANDERSKOPPEL 17, HAMBURG 2M 22391

Sangui Biotech International (Sangui Biotech International) Headlines

No Headlines